Unknown

Dataset Information

Comparison of efficacy and safety of leptin replacement therapy in moderately and severely hypoleptinemic patients with familial partial lipodystrophy of the Dunnigan variety.


ABSTRACT:

Context

Leptin replacement therapy improves metabolic complications in patients with lipodystrophy and severe hypoleptinemia (SH), but whether the response is related to the degree of hypoleptinemia remains unclear.

Objective

The aim of the study was to compare efficacy of leptin therapy in familial partial lipodystrophy, Dunnigan variety (FPLD) patients with SH (serum leptin<7th percentile of normal) vs. those with moderate hypoleptinemia (MH; serum leptin in 7th to 20th percentiles).

Design, setting, and patients

We conducted an open-label, parallel group, observational study in 14 SH (mean±sd, serum leptin, 1.9±1.1 ng/ml) and 10 MH (serum leptin, 5.3±1.0 ng/ml) women with FPLD.

Intervention

Patients received 0.08 mg/kg·d of metreleptin by twice daily sc inje

SUBMITTER: Simha V 

PROVIDER: S-EPMC3319219 | biostudies-literature | 2012 Mar

REPOSITORIES: biostudies-literature